1 Guidance

1 Guidance

This guidance updates and replaces:

1.1 Peginterferon alfa in combination with ribavirin is recommended, within its marketing authorisation, as an option for treating chronic hepatitis C in children and young people.

  • National Institute for Health and Care Excellence (NICE)